Machine Medicine is best understood as an objective digital phenotyping company for movement disorders, using computer vision and AI to quantify Parkinson’s symptoms for care and clinical trials. Its strength lies in reproducibility and trial utility, though it remains closer to biomarker infrastructure than therapeutics.